Response to antiviral therapy predicts the development of glucose abnormalities in patients with chronic HCV genotype 4 infection

被引：0
|
作者：
Chehadeh, W. [1 ]
Al-Nakib, W. [1 ]
机构：
[1] Kuwait Univ, Fac Med, Dept Microbiol, Virol Unit, Kuwait, Kuwait
来源：
JOURNAL OF CLINICAL VIROLOGY | 2009年 / 46卷
关键词：
D O I：
10.1016/S1386-6532(09)70153-2
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] HCV genotype 2a shows a better virological response to antiviral therapy than HCV genotype 1b
    Wang, Meng
    Li, Jiansheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 919 - 919
  • [32] HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
    Adriano M Pellicelli
    Mario Romano
    Tommaso Stroffolini
    Ettore Mazzoni
    Fabrizio Mecenate
    Roberto Monarca
    Antonio Picardi
    Maria Elena Bonaventura
    Cristina Mastropietro
    Pascal Vignally
    Arnaldo Andreoli
    Massimo Marignani
    Cecilia D’Ambrosio
    Lucia Miglioresi
    Lorenzo Nosotti
    Olga Mitidieri
    Umberto Vespasiani Gentilucci
    Claudio Puoti
    Giuseppe Barbaro
    Angelo Barlattani
    Caterina Furlan
    Giorgio Barbarini
    BMC Gastroenterology, 12
  • [33] INFLUENCE OF HCV GENOTYPE 1A AND GENOTYPE 1B ON THE VIROLOGICAL RESPONSE TO ANTIVIRAL THERAPY
    Pellicelli, Adriano M.
    Romano, Mario
    Barbarini, Giorgio
    Mazzoni, Ettore
    Mecenate, Fabrizio
    Furlan, Caterina
    Picardi, Antonio
    Bonaventura, Maria Elena
    Barbaro, Giuseppe
    Villani, Roberto
    D'Ambrosio, Cecilia
    Guarascio, Paolo
    Fondacaro, Lucia
    Cerasari, Giuseppe
    Lusi, Angela Elena
    Andreoli, Arnaldo
    Soccorsi, Fabrizio
    HEPATOLOGY, 2010, 52 (04) : 795A - 795A
  • [34] Viral Hepatitis ( plus Antiviral Therapy) IP-10 predicts therapeutic outcome in patients with HCV infection
    Lv, Juan
    Pan, Yu
    Jiang, Jing
    Wu, Ruihong
    Sun, Haibo
    Chi, Xiumei
    Wang, Xiaomei
    Niu, Junqi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 419 - 419
  • [35] How to optimize HCV therapy in genotype 4 patients
    Esmat, Gamal
    El Kassas, Mohamed
    Hassany, Mohamed
    Gamil, Mohamed Esmat
    El Raziky, Maisa
    LIVER INTERNATIONAL, 2013, 33 : 41 - 45
  • [36] Influence of SEN virus on the response to a combination therapy in patients with chronic HCV infection
    Sagir, A
    Ortwin, A
    Oliver, K
    Andreas, E
    Tobias, H
    Dieter, H
    JOURNAL OF HEPATOLOGY, 2003, 38 : 168 - 168
  • [37] ELEVATED SERUM IRON PREDICTS POOR RESPONSE TO INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HCV INFECTION
    ARBER, N
    MOSHKOWITZ, M
    KONIKOFF, F
    HALPERN, Z
    HALLAK, A
    SANTO, M
    TIOMNY, E
    BARATZ, M
    GILAT, T
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (11) : 2431 - 2433
  • [38] Sofosbuvir plus Ribavirin in the Treatment of Chronic HCV Genotype 4 Infection in Patients of Egyptian Ancestry
    Ruane, Peter J.
    Ain, Dani
    Riad, Joseph
    Meshrekey, Raymond G.
    Stryker, Richard
    Wolfe, Peter R.
    Basilyous, Lamese R.
    Jiang, Deyuan
    Knox, Steven J.
    Kersey, Kathryn
    Symonds, William T.
    HEPATOLOGY, 2013, 58 : 736A - 736A
  • [39] Ombitasvir/Paritaprevir/Ritonavir: A Review in Chronic HCV Genotype 4 Infection
    Gillian M. Keating
    Drugs, 2016, 76 : 1203 - 1211
  • [40] Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration
    Chan, Kee
    Lai, Mai Ngan
    Groessl, Erik J.
    Hanchate, Amresh D.
    Wong, John B.
    Clark, Jack A.
    Asch, Steven M.
    Gifford, Allen L.
    Ho, Samuel B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (11) : 1503 - 1510
12345